✦ LIBER ✦

In vivo assessment of decarboxylase inhibition or potentiation: Urinary dopamine and L-Dopa output after L-Dopa administration

✍ Scribed by R. D. Johnson; C. R. J. Ruthven; B. L. Goodwin; M. Sandler

Book ID: 105134636
Publisher: Springer
Year: 1976
Tongue: English
Weight: 666 KB
Volume: 38
Category: Article
ISSN: 1435-1463
DOI: 10.1007/bf01249438

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

DIFFERENTIATION IN BRAIN AND LIVER DOPA/

DIFFERENTIATION IN BRAIN AND LIVER DOPA/SHTP DECARBOXYLASE ACTIVITY AFTER L-DOPA ADMINISTRATION WITH OR WITHOUT PYRIDOXINE IN CATS

✍ A. G. Roberge 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 English ⚖ 588 KB

Ultrastructural evidence against in vivo

Ultrastructural evidence against in vivo disaggregation of brain polyribosomes after administration of L-dopa or phenylalanine

✍ J. F. Hartmann; Ruth A. Becker 📂 Article 📅 1973 🏛 Springer 🌐 English ⚖ 686 KB

The effects of central aromatic amino ac

The effects of central aromatic amino acid DOPA decarboxylase inhibition on the motor actions of L-DOPA and dopamine agonists in MPTP-treated primates

✍ Sarah A Treseder; Michael Jackson; Peter Jenner 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 499 KB

Striatal L-DOPA Decarboxylase Activity i

Striatal L-DOPA Decarboxylase Activity in Parkinson's Disease In Vivo: Implications for the Regulation of Dopamine Synthesis

✍ Albert Gjedde; Gabriel C. Léger; Paul Cumming; Yoshifumi Yasuhara; Alan C. Evans 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 389 KB

Increased neostriatal dopamine activity

Increased neostriatal dopamine activity after intraperitoneal or intranasal administration of L-DOPA: On the role of benserazide pretreatment

✍ M.A. de Souza Silva; C. Mattern; R. Häcker; C. Tomaz; J.P. Huston; R.K.W. Schwar 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB

L-DOPA provides the most potent medication to treat Parkinson's disease, and such systemic treatment is usually combined with a peripheral amino acid decarboxylase inhibitor to amplify its central effectiveness. Since L-DOPA can lose its efficacy or can lead to adverse effects with prolonged applica

EFFECT OF l-DOPA ON BRAIN CONCENTRATION

EFFECT OF l-DOPA ON BRAIN CONCENTRATION OF DOPAMINE AND HOMOVANILLIC ACID IN RATS AFTER CHRONIC MANGANESE CHLORIDE ADMINISTRATION

✍ E. Bonilla; María Diez-Ewald 📂 Article 📅 1974 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB